Global Protein Engineering Market to Reach $7.8 Billion by 2030

New York, May 11, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Protein Engineering Industry" - https://www.reportlinker.com/p06032695/?utm_source=GNW
Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China’s already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Protein Engineering Market to Reach $7.8 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Protein Engineering estimated at US$3.1 Billion in the year 2022, is projected to reach a revised size of US$7.8 Billion by 2030, growing at aCAGR of 12.4% over the period 2022-2030. Instruments, one of the segments analyzed in the report, is projected to record 11.5% CAGR and reach US$3.3 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Reagents segment is readjusted to a revised 12.6% CAGR for the next 8-year period.

The U.S. Market is Estimated at $835.9 Million, While China is Forecast to Grow at 18.2% CAGR

The Protein Engineering market in the U.S. is estimated at US$835.9 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$2 Billion by the year 2030 trailing a CAGR of 18.2% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.5% and 9.9% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 7.9% CAGR.

Select Competitors (Total 18 Featured)
- Abzena, Ltd.
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
- Bruker Corporation
- Codexis, Inc.
- Creative Biolabs
- Danaher Corporation
- Enantis S.R.O.
- GE Healthcare
- Genscript Biotech Corporation
- Innovagen AB
- Merck KGaA
- New England Biolabs, Inc.
- Perkinelmer, Inc.
- Phynexus, Inc. (A Part of Biotage)
- Promega Corporation
- Proteogenix
- Takara Bio, Inc.
- Thermo Fisher Scientific, Inc.
- Waters Corporation


Read the full report: https://www.reportlinker.com/p06032695/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
Protein Engineering - Global Key Competitors Percentage Market
Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for
Rational Protein Design by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2022 through 2030 and % CAGR

Table 2: World Historic Review for Rational Protein Design by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR

Table 3: World 16-Year Perspective for Rational Protein Design
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030

Table 4: World Recent Past, Current & Future Analysis for
Directed Evolution by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2022 through 2030 and % CAGR

Table 5: World Historic Review for Directed Evolution by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR

Table 6: World 16-Year Perspective for Directed Evolution by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030

Table 7: World Recent Past, Current & Future Analysis for
Hybrid Approach by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2022 through 2030 and % CAGR

Table 8: World Historic Review for Hybrid Approach by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR

Table 9: World 16-Year Perspective for Hybrid Approach by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030

Table 10: World Recent Past, Current & Future Analysis for
Pharma & Biotech Companies by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2022 through 2030 and % CAGR

Table 11: World Historic Review for Pharma & Biotech Companies
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR

Table 12: World 16-Year Perspective for Pharma & Biotech
Companies by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2014, 2023 &
2030

Table 13: World Recent Past, Current & Future Analysis for
Contract Research Organizations by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2022 through 2030 and % CAGR

Table 14: World Historic Review for Contract Research
Organizations by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2014 through 2021 and % CAGR

Table 15: World 16-Year Perspective for Contract Research
Organizations by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa for Years
2014, 2023 & 2030

Table 16: World Recent Past, Current & Future Analysis for
Academic Research Institutes by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2022 through 2030 and % CAGR

Table 17: World Historic Review for Academic Research
Institutes by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2014 through 2021 and % CAGR

Table 18: World 16-Year Perspective for Academic Research
Institutes by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2014, 2023 &
2030

Table 19: World Protein Engineering Market Analysis of Annual
Sales in US$ Thousand for Years 2014 through 2030

Table 20: World Recent Past, Current & Future Analysis for
Protein Engineering by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2022 through 2030 and % CAGR

Table 21: World Historic Review for Protein Engineering by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR

Table 22: World 16-Year Perspective for Protein Engineering by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets for Years 2014, 2023 & 2030

Table 23: World Recent Past, Current & Future Analysis for
Instruments by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2022 through 2030 and % CAGR

Table 24: World Historic Review for Instruments by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2014 through 2021 and
% CAGR

Table 25: World 16-Year Perspective for Instruments by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030

Table 26: World Recent Past, Current & Future Analysis for
Reagents by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2022 through 2030 and % CAGR

Table 27: World Historic Review for Reagents by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2014 through 2021 and
% CAGR

Table 28: World 16-Year Perspective for Reagents by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2014, 2023 & 2030

Table 29: World Recent Past, Current & Future Analysis for
Software & Services by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2022 through 2030 and % CAGR

Table 30: World Historic Review for Software & Services by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR

Table 31: World 16-Year Perspective for Software & Services by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030

III. MARKET ANALYSIS

UNITED STATES
Protein Engineering Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in the United States for 2023 (E)
Table 32: USA Recent Past, Current & Future Analysis for
Protein Engineering by Technology - Rational Protein Design,
Directed Evolution and Hybrid Approach - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2022 through 2030
and % CAGR

Table 33: USA Historic Review for Protein Engineering by
Technology - Rational Protein Design, Directed Evolution and
Hybrid Approach Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2014 through 2021 and % CAGR

Table 34: USA 16-Year Perspective for Protein Engineering by
Technology - Percentage Breakdown of Value Sales for Rational
Protein Design, Directed Evolution and Hybrid Approach for the
Years 2014, 2023 & 2030

Table 35: USA Recent Past, Current & Future Analysis for
Protein Engineering by End-Use - Pharma & Biotech Companies,
Contract Research Organizations and Academic Research
Institutes - Independent Analysis of Annual Sales in US$
Thousand for the Years 2022 through 2030 and % CAGR

Table 36: USA Historic Review for Protein Engineering by
End-Use - Pharma & Biotech Companies, Contract Research
Organizations and Academic Research Institutes Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR

Table 37: USA 16-Year Perspective for Protein Engineering by
End-Use - Percentage Breakdown of Value Sales for Pharma &
Biotech Companies, Contract Research Organizations and Academic
Research Institutes for the Years 2014, 2023 & 2030

Table 38: USA Recent Past, Current & Future Analysis for
Protein Engineering by Product - Instruments, Reagents and
Software & Services - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2022 through 2030 and % CAGR

Table 39: USA Historic Review for Protein Engineering by
Product - Instruments, Reagents and Software & Services Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2014 through 2021 and % CAGR

Table 40: USA 16-Year Perspective for Protein Engineering by
Product - Percentage Breakdown of Value Sales for Instruments,
Reagents and Software & Services for the Years 2014, 2023 &
2030

CANADA
Table 41: Canada Recent Past, Current & Future Analysis for
Protein Engineering by Technology - Rational Protein Design,
Directed Evolution and Hybrid Approach - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2022 through 2030
and % CAGR

Table 42: Canada Historic Review for Protein Engineering by
Technology - Rational Protein Design, Directed Evolution and
Hybrid Approach Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2014 through 2021 and % CAGR

Table 43: Canada 16-Year Perspective for Protein Engineering by
Technology - Percentage Breakdown of Value Sales for Rational
Protein Design, Directed Evolution and Hybrid Approach for the
Years 2014, 2023 & 2030

Table 44: Canada Recent Past, Current & Future Analysis for
Protein Engineering by End-Use - Pharma & Biotech Companies,
Contract Research Organizations and Academic Research
Institutes - Independent Analysis of Annual Sales in US$
Thousand for the Years 2022 through 2030 and % CAGR

Table 45: Canada Historic Review for Protein Engineering by
End-Use - Pharma & Biotech Companies, Contract Research
Organizations and Academic Research Institutes Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR

Table 46: Canada 16-Year Perspective for Protein Engineering by
End-Use - Percentage Breakdown of Value Sales for Pharma &
Biotech Companies, Contract Research Organizations and Academic
Research Institutes for the Years 2014, 2023 & 2030

Table 47: Canada Recent Past, Current & Future Analysis for
Protein Engineering by Product - Instruments, Reagents and
Software & Services - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2022 through 2030 and % CAGR

Table 48: Canada Historic Review for Protein Engineering by
Product - Instruments, Reagents and Software & Services Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2014 through 2021 and % CAGR

Table 49: Canada 16-Year Perspective for Protein Engineering by
Product - Percentage Breakdown of Value Sales for Instruments,
Reagents and Software & Services for the Years 2014, 2023 &
2030

JAPAN
Protein Engineering Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Japan for 2023 (E)
Table 50: Japan Recent Past, Current & Future Analysis for
Protein Engineering by Technology - Rational Protein Design,
Directed Evolution and Hybrid Approach - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2022 through 2030
and % CAGR

Table 51: Japan Historic Review for Protein Engineering by
Technology - Rational Protein Design, Directed Evolution and
Hybrid Approach Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2014 through 2021 and % CAGR

Table 52: Japan 16-Year Perspective for Protein Engineering by
Technology - Percentage Breakdown of Value Sales for Rational
Protein Design, Directed Evolution and Hybrid Approach for the
Years 2014, 2023 & 2030

Table 53: Japan Recent Past, Current & Future Analysis for
Protein Engineering by End-Use - Pharma & Biotech Companies,
Contract Research Organizations and Academic Research
Institutes - Independent Analysis of Annual Sales in US$
Thousand for the Years 2022 through 2030 and % CAGR

Table 54: Japan Historic Review for Protein Engineering by
End-Use - Pharma & Biotech Companies, Contract Research
Organizations and Academic Research Institutes Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR

Table 55: Japan 16-Year Perspective for Protein Engineering by
End-Use - Percentage Breakdown of Value Sales for Pharma &
Biotech Companies, Contract Research Organizations and Academic
Research Institutes for the Years 2014, 2023 & 2030

Table 56: Japan Recent Past, Current & Future Analysis for
Protein Engineering by Product - Instruments, Reagents and
Software & Services - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2022 through 2030 and % CAGR

Table 57: Japan Historic Review for Protein Engineering by
Product - Instruments, Reagents and Software & Services Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2014 through 2021 and % CAGR

Table 58: Japan 16-Year Perspective for Protein Engineering by
Product - Percentage Breakdown of Value Sales for Instruments,
Reagents and Software & Services for the Years 2014, 2023 &
2030

CHINA
Protein Engineering Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in China for 2023 (E)
Table 59: China Recent Past, Current & Future Analysis for
Protein Engineering by Technology - Rational Protein Design,
Directed Evolution and Hybrid Approach - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2022 through 2030
and % CAGR

Table 60: China Historic Review for Protein Engineering by
Technology - Rational Protein Design, Directed Evolution and
Hybrid Approach Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2014 through 2021 and % CAGR

Table 61: China 16-Year Perspective for Protein Engineering by
Technology - Percentage Breakdown of Value Sales for Rational
Protein Design, Directed Evolution and Hybrid Approach for the
Years 2014, 2023 & 2030

Table 62: China Recent Past, Current & Future Analysis for
Protein Engineering by End-Use - Pharma & Biotech Companies,
Contract Research Organizations and Academic Research
Institutes - Independent Analysis of Annual Sales in US$
Thousand for the Years 2022 through 2030 and % CAGR

Table 63: China Historic Review for Protein Engineering by
End-Use - Pharma & Biotech Companies, Contract Research
Organizations and Academic Research Institutes Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR

Table 64: China 16-Year Perspective for Protein Engineering by
End-Use - Percentage Breakdown of Value Sales for Pharma &
Biotech Companies, Contract Research Organizations and Academic
Research Institutes for the Years 2014, 2023 & 2030

Table 65: China Recent Past, Current & Future Analysis for
Protein Engineering by Product - Instruments, Reagents and
Software & Services - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2022 through 2030 and % CAGR

Table 66: China Historic Review for Protein Engineering by
Product - Instruments, Reagents and Software & Services Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2014 through 2021 and % CAGR

Table 67: China 16-Year Perspective for Protein Engineering by
Product - Percentage Breakdown of Value Sales for Instruments,
Reagents and Software & Services for the Years 2014, 2023 &
2030

EUROPE
Protein Engineering Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Europe for 2023 (E)
Table 68: Europe Recent Past, Current & Future Analysis for
Protein Engineering by Technology - Rational Protein Design,
Directed Evolution and Hybrid Approach - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2022 through 2030
and % CAGR

Table 69: Europe Historic Review for Protein Engineering by
Technology - Rational Protein Design, Directed Evolution and
Hybrid Approach Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2014 through 2021 and % CAGR

Table 70: Europe 16-Year Perspective for Protein Engineering by
Technology - Percentage Breakdown of Value Sales for Rational
Protein Design, Directed Evolution and Hybrid Approach for the
Years 2014, 2023 & 2030

Table 71: Europe Recent Past, Current & Future Analysis for
Protein Engineering by End-Use - Pharma & Biotech Companies,
Contract Research Organizations and Academic Research
Institutes - Independent Analysis of Annual Sales in US$
Thousand for the Years 2022 through 2030 and % CAGR

Table 72: Europe Historic Review for Protein Engineering by
End-Use - Pharma & Biotech Companies, Contract Research
Organizations and Academic Research Institutes Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR

Table 73: Europe 16-Year Perspective for Protein Engineering by
End-Use - Percentage Breakdown of Value Sales for Pharma &
Biotech Companies, Contract Research Organizations and Academic
Research Institutes for the Years 2014, 2023 & 2030

Table 74: Europe Recent Past, Current & Future Analysis for
Protein Engineering by Geographic Region - France, Germany,
Italy, UK, Spain, Russia and Rest of Europe Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2022 through 2030 and % CAGR

Table 75: Europe Historic Review for Protein Engineering by
Geographic Region - France, Germany, Italy, UK, Spain, Russia
and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2014 through 2021 and % CAGR

Table 76: Europe 16-Year Perspective for Protein Engineering by
Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK, Spain, Russia and Rest of Europe
Markets for Years 2014, 2023 & 2030

Table 77: Europe Recent Past, Current & Future Analysis for
Protein Engineering by Product - Instruments, Reagents and
Software & Services - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2022 through 2030 and % CAGR

Table 78: Europe Historic Review for Protein Engineering by
Product - Instruments, Reagents and Software & Services Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2014 through 2021 and % CAGR

Table 79: Europe 16-Year Perspective for Protein Engineering by
Product - Percentage Breakdown of Value Sales for Instruments,
Reagents and Software & Services for the Years 2014, 2023 &
2030

FRANCE
Protein Engineering Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in France for 2023 (E)
Table 80: France Recent Past, Current & Future Analysis for
Protein Engineering by Technology - Rational Protein Design,
Directed Evolution and Hybrid Approach - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2022 through 2030
and % CAGR

Table 81: France Historic Review for Protein Engineering by
Technology - Rational Protein Design, Directed Evolution and
Hybrid Approach Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2014 through 2021 and % CAGR

Table 82: France 16-Year Perspective for Protein Engineering by
Technology - Percentage Breakdown of Value Sales for Rational
Protein Design, Directed Evolution and Hybrid Approach for the
Years 2014, 2023 & 2030

Table 83: France Recent Past, Current & Future Analysis for
Protein Engineering by End-Use - Pharma & Biotech Companies,
Contract Research Organizations and Academic Research
Institutes - Independent Analysis of Annual Sales in US$
Thousand for the Years 2022 through 2030 and % CAGR

Table 84: France Historic Review for Protein Engineering by
End-Use - Pharma & Biotech Companies, Contract Research
Organizations and Academic Research Institutes Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR

Table 85: France 16-Year Perspective for Protein Engineering by
End-Use - Percentage Breakdown of Value Sales for Pharma &
Biotech Companies, Contract Research Organizations and Academic
Research Institutes for the Years 2014, 2023 & 2030

Table 86: France Recent Past, Current & Future Analysis for
Protein Engineering by Product - Instruments, Reagents and
Software & Services - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2022 through 2030 and % CAGR

Table 87: France Historic Review for Protein Engineering by
Product - Instruments, Reagents and Software & Services Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2014 through 2021 and % CAGR

Table 88: France 16-Year Perspective for Protein Engineering by
Product - Percentage Breakdown of Value Sales for Instruments,
Reagents and Software & Services for the Years 2014, 2023 &
2030

GERMANY
Protein Engineering Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Germany for 2023 (E)
Table 89: Germany Recent Past, Current & Future Analysis for
Protein Engineering by Technology - Rational Protein Design,
Directed Evolution and Hybrid Approach - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2022 through 2030
and % CAGR

Table 90: Germany Historic Review for Protein Engineering by
Technology - Rational Protein Design, Directed Evolution and
Hybrid Approach Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2014 through 2021 and % CAGR

Table 91: Germany 16-Year Perspective for Protein Engineering
by Technology - Percentage Breakdown of Value Sales for
Rational Protein Design, Directed Evolution and Hybrid Approach
for the Years 2014, 2023 & 2030

Table 92: Germany Recent Past, Current & Future Analysis for
Protein Engineering by End-Use - Pharma & Biotech Companies,
Contract Research Organizations and Academic Research
Institutes - Independent Analysis of Annual Sales in US$
Thousand for the Years 2022 through 2030 and % CAGR

Table 93: Germany Historic Review for Protein Engineering by
End-Use - Pharma & Biotech Companies, Contract Research
Organizations and Academic Research Institutes Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR

Table 94: Germany 16-Year Perspective for Protein Engineering
by End-Use - Percentage Breakdown of Value Sales for Pharma &
Biotech Companies, Contract Research Organizations and Academic
Research Institutes for the Years 2014, 2023 & 2030

Table 95: Germany Recent Past, Current & Future Analysis for
Protein Engineering by Product - Instruments, Reagents and
Software & Services - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2022 through 2030 and % CAGR

Table 96: Germany Historic Review for Protein Engineering by
Product - Instruments, Reagents and Software & Services Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2014 through 2021 and % CAGR

Table 97: Germany 16-Year Perspective for Protein Engineering
by Product - Percentage Breakdown of Value Sales for
Instruments, Reagents and Software & Services for the Years
2014, 2023 & 2030

ITALY
Table 98: Italy Recent Past, Current & Future Analysis for
Protein Engineering by Technology - Rational Protein Design,
Directed Evolution and Hybrid Approach - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2022 through 2030
and % CAGR

Table 99: Italy Historic Review for Protein Engineering by
Technology - Rational Protein Design, Directed Evolution and
Hybrid Approach Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2014 through 2021 and % CAGR

Table 100: Italy 16-Year Perspective for Protein Engineering by
Technology - Percentage Breakdown of Value Sales for Rational
Protein Design, Directed Evolution and Hybrid Approach for the
Years 2014, 2023 & 2030

Table 101: Italy Recent Past, Current & Future Analysis for
Protein Engineering by End-Use - Pharma & Biotech Companies,
Contract Research Organizations and Academic Research
Institutes - Independent Analysis of Annual Sales in US$
Thousand for the Years 2022 through 2030 and % CAGR

Table 102: Italy Historic Review for Protein Engineering by
End-Use - Pharma & Biotech Companies, Contract Research
Organizations and Academic Research Institutes Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR

Table 103: Italy 16-Year Perspective for Protein Engineering by
End-Use - Percentage Breakdown of Value Sales for Pharma &
Biotech Companies, Contract Research Organizations and Academic
Research Institutes for the Years 2014, 2023 & 2030

Table 104: Italy Recent Past, Current & Future Analysis for
Protein Engineering by Product - Instruments, Reagents and
Software & Services - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2022 through 2030 and % CAGR

Table 105: Italy Historic Review for Protein Engineering by
Product - Instruments, Reagents and Software & Services Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2014 through 2021 and % CAGR

Table 106: Italy 16-Year Perspective for Protein Engineering by
Product - Percentage Breakdown of Value Sales for Instruments,
Reagents and Software & Services for the Years 2014, 2023 &
2030

UNITED KINGDOM
Protein Engineering Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in the United Kingdom for 2023 (E)
Table 107: UK Recent Past, Current & Future Analysis for
Protein Engineering by Technology - Rational Protein Design,
Directed Evolution and Hybrid Approach - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2022 through 2030
and % CAGR

Table 108: UK Historic Review for Protein Engineering by
Technology - Rational Protein Design, Directed Evolution and
Hybrid Approach Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2014 through 2021 and % CAGR

Table 109: UK 16-Year Perspective for Protein Engineering by
Technology - Percentage Breakdown of Value Sales for Rational
Protein Design, Directed Evolution and Hybrid Approach for the
Years 2014, 2023 & 2030

Table 110: UK Recent Past, Current & Future Analysis for
Protein Engineering by End-Use - Pharma & Biotech Companies,
Contract Research Organizations and Academic Research
Institutes - Independent Analysis of Annual Sales in US$
Thousand for the Years 2022 through 2030 and % CAGR

Table 111: UK Historic Review for Protein Engineering by
End-Use - Pharma & Biotech Companies, Contract Research
Organizations and Academic Research Institutes Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR

Table 112: UK 16-Year Perspective for Protein Engineering by
End-Use - Percentage Breakdown of Value Sales for Pharma &
Biotech Companies, Contract Research Organizations and Academic
Research Institutes for the Years 2014, 2023 & 2030

Table 113: UK Recent Past, Current & Future Analysis for
Protein Engineering by Product - Instruments, Reagents and
Software & Services - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2022 through 2030 and % CAGR

Table 114: UK Historic Review for Protein Engineering by
Product - Instruments, Reagents and Software & Services Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2014 through 2021 and % CAGR

Table 115: UK 16-Year Perspective for Protein Engineering by
Product - Percentage Breakdown of Value Sales for Instruments,
Reagents and Software & Services for the Years 2014, 2023 &
2030

SPAIN
Table 116: Spain Recent Past, Current & Future Analysis for
Protein Engineering by Technology - Rational Protein Design,
Directed Evolution and Hybrid Approach - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2022 through 2030
and % CAGR

Table 117: Spain Historic Review for Protein Engineering by
Technology - Rational Protein Design, Directed Evolution and
Hybrid Approach Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2014 through 2021 and % CAGR

Table 118: Spain 16-Year Perspective for Protein Engineering by
Technology - Percentage Breakdown of Value Sales for Rational
Protein Design, Directed Evolution and Hybrid Approach for the
Years 2014, 2023 & 2030

Table 119: Spain Recent Past, Current & Future Analysis for
Protein Engineering by End-Use - Pharma & Biotech Companies,
Contract Research Organizations and Academic Research
Institutes - Independent Analysis of Annual Sales in US$
Thousand for the Years 2022 through 2030 and % CAGR

Table 120: Spain Historic Review for Protein Engineering by
End-Use - Pharma & Biotech Companies, Contract Research
Organizations and Academic Research Institutes Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR

Table 121: Spain 16-Year Perspective for Protein Engineering by
End-Use - Percentage Breakdown of Value Sales for Pharma &
Biotech Companies, Contract Research Organizations and Academic
Research Institutes for the Years 2014, 2023 & 2030

Table 122: Spain Recent Past, Current & Future Analysis for
Protein Engineering by Product - Instruments, Reagents and
Software & Services - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2022 through 2030 and % CAGR

Table 123: Spain Historic Review for Protein Engineering by
Product - Instruments, Reagents and Software & Services Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2014 through 2021 and % CAGR

Table 124: Spain 16-Year Perspective for Protein Engineering by
Product - Percentage Breakdown of Value Sales for Instruments,

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p06032695/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

              Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001